Clinical Trial Update: Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes [NA]

View source ↗

Summary

This clinical trial update indicates that Endogenex, Inc. is actively recruiting participants to evaluate the safety and effectiveness of an endoscopic intestin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Endoscopic Intestinal Re-Cellularization Therapy

Snippet

Sponsor: Endogenex, Inc. | Conditions: Type 2 Diabetes Mellitus, Type2diabetes | NA | Status: RECRUITING